妊婦用ビタミンサプリメントの世界市場

◆英語タイトル:Global Prenatal Vitamin Supplements Market
◆商品コード:IRTNTR41009
◆発行会社(リサーチ会社):Technavio
◆発行日:2020年2月13日
◆ページ数:120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥267,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥321,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥428,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Global prenatal vitamin supplements market 2020-2024
Technavio has been monitoring the global prenatal vitamin supplements market and it is poised to grow by USD 195.69 mn during 2020-2024, progressing at a CAGR of 8% during the forecast period. Our reports on global prenatal vitamin supplements market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing number of gynecologists recommending prenatal vitamin supplements to expecting mothers.
In addition, usage of artificial intelligence by prenatal vitamin supplement manufacturing players is anticipated to boost the growth of the global prenatal vitamin supplements market as well.

Market Segmentation

Technavio’s global prenatal vitamin supplements market is segmented as below:
Distribution channelConventional retail channels Direct selling and e-retailingGeographic segmentationNorth America APAC Europe South America MEA
Key Trends for global prenatal vitamin supplements market growth

This study identifies usage of artificial intelligence by prenatal vitamin supplement manufacturing players as the prime reasons driving the global prenatal vitamin supplements market growth during the next few years.

Prominent vendors in global prenatal vitamin supplements market

We provide a detailed analysis of around 25 vendors operating in the global prenatal vitamin supplements market, including some of the vendors such as Abbott Laboratories, Atrium Innovations Inc., Bayer AG, Church & Dwight Co. Inc., FoodState Inc., Nordic Naturals, Nutranext, Otsuka Holdings Co. Ltd., The Procter & Gamble Co. and TherapeuticsMD Inc. .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/prenatal-vitamin-supplements-market-industry-analysis

About Technavio
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【レポートの目次】

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
• Five Forces Analysis
o Five Forces Summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Distribution channel
o Market segments
o Comparison by Distribution channel placement
o Conventional retail channels – Market size and forecast 2019-2024
o Direct selling and e-retailing – Market size and forecast 2019-2024
o Market opportunity by Distribution channel
• Customer landscape
o Overview
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2019-2024
o Europe – Market size and forecast 2019-2024
o APAC – Market size and forecast 2019-2024
o South America – Market size and forecast 2019-2024
o MEA – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
• Drivers, Challenges, and Trends
o Market drivers
o Volume driver – Demand led growth
o Volume driver – Supply led growth
o Volume driver – External factors
o Volume driver – Demand shift in adjacent markets
o Price driver – Inflation
o Price driver – Shift from lower to higher priced units
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Abbott Laboratories
o Atrium Innovations Inc.
o Bayer AG
o Church & Dwight Co. Inc.
o FoodState Inc.
o Nordic Naturals
o Nutranext
o Otsuka Holdings Co. Ltd.
o The Procter & Gamble Co.
o TherapeuticsMD Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
• Exhibits
• 1.Key Finding 1
• 2.Key Finding 2
• 3.Key Finding 3
• 4.Key Finding 4
• 5.Key Finding 5
• 6.Key Finding 6
• 7.Key Finding 7
• 8.Market in focus
• 9.Parent market
• 10.Market characteristics
• 11.Product / Service portfolio of key vendors included in the market definition
• 12.Market segments
• 13.Global – Market size and forecast 2019 – 2024 ($ million)
• 14.Global market: Year-over-year growth 2019 – 2024 (%)
• 15.Five forces analysis 2019 & 2024
• 16.Bargaining power of buyers
• 17.Bargaining power of suppliers
• 18.Threat of new entrants
• 19.Threat of substitutes
• 20.Threat of rivalry
• 21.Market condition – Five forces 2019
• 22.Distribution channel placement – Market share 2019-2024 (%)
• 23.Comparison by Distribution channel placement
• 24.Conventional retail channels – Market size and forecast 2019-2024 ($ million)
• 25.Conventional retail channels – Year-over-year growth 2019-2024 (%)
• 26.Direct selling and e-retailing – Market size and forecast 2019-2024 ($ million)
• 27.Direct selling and e-retailing – Year-over-year growth 2019-2024 (%)
• 28. Market opportunity by Distribution channel
• 29.Customer landscape
• 30.Market share by geography 2019-2024 (%)
• 31.Geographic comparison
• 32.North America – Market size and forecast 2019-2024 ($ million)
• 33.North America – Year-over-year growth 2019-2024 (%)
• 34.Europe – Market size and forecast 2019-2024 ($ million)
• 35.Europe – Year-over-year growth 2019-2024 (%)
• 36.APAC – Market size and forecast 2019-2024 ($ million)
• 37.APAC – Year-over-year growth 2019-2024 (%)
• 38.South America – Market size and forecast 2019-2024 ($ million)
• 39.South America – Year-over-year growth 2019-2024 (%)
• 40.MEA – Market size and forecast 2019-2024 ($ million)
• 41.MEA – Year-over-year growth 2019-2024 (%)
• 42.Key leading countries
• 43.Market opportunity by geography ($ million)
• 44.Impact of drivers
• 45.Impact of challenges
• 46.Landscape disruption
• 47.Industry risks
• 48.Vendors covered
• 49.Market positioning of vendors
• 50.Abbott Laboratories – Overview (1/3)
• 51.Abbott Laboratories – Overview (2/3)
• 52.Abbott Laboratories – Overview (3/3)
• 53.Abbott Laboratories – Business segments
• 54.Abbott Laboratories – Key offerings
• 55.Abbott Laboratories – Key customers
• 56.Abbott Laboratories – Segment focus
• 57.Atrium Innovations Inc. – Overview (1/3)
• 58.Atrium Innovations Inc. – Overview (2/3)
• 59.Atrium Innovations Inc. – Overview (3/3)
• 60.Atrium Innovations Inc. – Business segments
• 61.Atrium Innovations Inc. – Key offerings
• 62.Atrium Innovations Inc. – Key customers
• 63.Atrium Innovations Inc. – Segment focus
• 64.Bayer AG – Overview (1/3)
• 65.Bayer AG – Overview (2/3)
• 66.Bayer AG – Overview (3/3)
• 67.Bayer AG – Business segments
• 68.Bayer AG – Key offerings
• 69.Bayer AG – Key customers
• 70.Bayer AG – Segment focus
• 71.Church & Dwight Co. Inc. – Overview (1/3)
• 72.Church & Dwight Co. Inc. – Overview (2/3)
• 73.Church & Dwight Co. Inc. – Overview (3/3)
• 74.Church & Dwight Co. Inc. – Business segments
• 75.Church & Dwight Co. Inc. – Key offerings
• 76.Church & Dwight Co. Inc. – Key customers
• 77.Church & Dwight Co. Inc. – Segment focus
• 78.FoodState Inc. – Overview (1/3)
• 79.FoodState Inc. – Overview (2/3)
• 80.FoodState Inc. – Overview (3/3)
• 81.FoodState Inc. – Product and service
• 82.FoodState Inc. – Key offerings
• 83.FoodState Inc. – Key customers
• 84.FoodState Inc. – Segment focus
• 85.Nordic Naturals – Overview (1/3)
• 86.Nordic Naturals – Overview (2/3)
• 87.Nordic Naturals – Overview (3/3)
• 88.Nordic Naturals – Business segments
• 89.Nordic Naturals – Key offerings
• 90.Nordic Naturals – Key customers
• 91.Nordic Naturals – Segment focus
• 92.Nutranext – Overview (1/3)
• 93.Nutranext – Overview (2/3)
• 94.Nutranext – Overview (3/3)
• 95.Nutranext – Business segments
• 96.Nutranext – Key offerings
• 97.Nutranext – Key customers
• 98.Nutranext – Segment focus
• 99.Otsuka Holdings Co. Ltd. – Overview (1/3)
• 100.Otsuka Holdings Co. Ltd. – Overview (2/3)
• 101.Otsuka Holdings Co. Ltd. – Overview (3/3)
• 102.Otsuka Holdings Co. Ltd. – Business segments
• 103.Otsuka Holdings Co. Ltd. – Key offerings
• 104.Otsuka Holdings Co. Ltd. – Key customers
• 105.Otsuka Holdings Co. Ltd. – Segment focus
• 106.The Procter & Gamble Co. – Overview (1/3)
• 107.The Procter & Gamble Co. – Overview (2/3)
• 108.The Procter & Gamble Co. – Overview (3/3)
• 109.The Procter & Gamble Co. – Business segments
• 110.The Procter & Gamble Co. – Key offerings
• 111.The Procter & Gamble Co. – Key customers
• 112.The Procter & Gamble Co. – Segment focus
• 113.TherapeuticsMD Inc. – Overview (1/3)
• 114.TherapeuticsMD Inc. – Overview (2/3)
• 115.TherapeuticsMD Inc. – Overview (3/3)
• 116.TherapeuticsMD Inc. – Business segments
• 117.TherapeuticsMD Inc. – Key offerings
• 118.TherapeuticsMD Inc. – Key customers
• 119.TherapeuticsMD Inc. – Segment focus
• 120.Currency conversion rates for US$
• 121.Research Methodology
• 122.Validation techniques employed for market sizing
• 123.Information sources
• 124.List of abbreviations



【掲載企業】

Abbott Laboratories
Atrium Innovations Inc.
Bayer AG
Church & Dwight Co. Inc.
FoodState Inc.
Nordic Naturals
Nutranext
Otsuka Holdings Co. Ltd.
The Procter & Gamble Co.
TherapeuticsMD Inc.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[妊婦用ビタミンサプリメントの世界市場]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆